Feature Channels: Cardiovascular Health

Filters close
Newswise: Common drug for cardiac failure jams a debated blood test for Alzheimer’s disease
Released: 19-Dec-2023 12:05 PM EST
Common drug for cardiac failure jams a debated blood test for Alzheimer’s disease
University of Gothenburg

Alzheimer’s disease (AD) is associated with damaging protein aggregates in the brain, with β-amyloid (Aβ) aggregates called plaques being the key pathology. Entresto (sacubitril/valsartan) is a combined neprilysin inhibitor and angiotensin receptor blocker, approved for the treatment of heart failure.

Released: 19-Dec-2023 11:05 AM EST
UNM Professor Develops Vaccine to Lower Cholesterol
University of New Mexico Comprehensive Cancer Center

Nearly two in five U.S. adults have high cholesterol, according to the Centers for Disease Control and Prevention (CDC).

Released: 18-Dec-2023 10:05 AM EST
Unstable ‘fluttering’ predicts aortic aneurysm
Northwestern University

Northwestern University researchers have developed the first physics-based metric to predict whether or not a person might someday suffer an aortic aneurysm, a deadly condition that often causes no symptoms until it ruptures.

13-Dec-2023 11:05 AM EST
Multi-Site Study Reveals Addressable Socioeconomic Barriers to Prenatal Diagnosis of Congenital Heart Defects
Ann and Robert H. Lurie Children's Hospital of Chicago

Prenatal diagnosis of congenital heart defects – the most common birth defects in the United States – is associated with improved outcomes. Despite its importance, however, overall prevalence of prenatal diagnosis is low (12-50 percent). A recent multi-center study surveyed caretakers of infants who received congenital heart surgery in the Chicago area and found that social determinants or influencers of health constitute significant barriers to prenatal diagnosis from the patients’ perspective.

Newswise: Exploring the effects of vascularization strategies on brain organoids
Released: 15-Dec-2023 2:05 PM EST
Exploring the effects of vascularization strategies on brain organoids
Waseda University

Cerebral organoids are three-dimensional, in vitro cultured brains that mimic the activities of the human brain. They have emerged as invaluable tools to comprehend evolution, disease pathogenesis, and neurodevelopmental processes. However, the development of these organoids is still in nascent stages with several limitations that hinder their broad applications. A major obstacle is the absence of a functional vasculature that can restrict the size of organoids, trigger cell death, and prevent cell differentiation in the organoids.

   
Newswise: New Artificial Intelligence Tool Predicts Mortality After Surgeries and Procedures
Released: 15-Dec-2023 11:05 AM EST
New Artificial Intelligence Tool Predicts Mortality After Surgeries and Procedures
Cedars-Sinai

An artificial intelligence (AI) tool developed by investigators at the Smidt Heart Institute at Cedars-Sinai and colleagues at two other institutions accurately predicted how patients would fare after surgeries and procedures.

Released: 15-Dec-2023 10:05 AM EST
Eating meals early could reduce cardiovascular risk
INRAE - National Research Institute for Agriculture, Food and Environment

Cardiovascular diseases are the leading cause of death in the world according to the Global Burden of Disease study, with 18.6 million annual deaths in 2019, of which around 7.9 are attributable to diet. This means that diet plays a major role in the development and progression of these diseases.

Released: 15-Dec-2023 9:30 AM EST
UMSOM Researchers Discover First Ever Link Between Hemoglobin-Like Protein and Normal Heart Development
University of Maryland School of Medicine

In a landmark study led by the University of Maryland School of Medicine, researchers discovered for the first time that a certain kind of protein similar to hemoglobin, called cytoglobin, plays an important role in the development of the heart.

Newswise: Experts Offer Virtual Second Opinions for Women With Heart Conditions
Released: 14-Dec-2023 11:05 PM EST
Experts Offer Virtual Second Opinions for Women With Heart Conditions
Cedars-Sinai

The Smidt Heart Institute at Cedars-Sinai has expanded its popular Virtual Second Opinion Program to women living with or at risk of developing heart disease, the nation’s leading cause of death in women.

Released: 14-Dec-2023 2:05 PM EST
High cholesterol caused by childhood sedentariness could be reversed with light physical activity
University of Exeter

Increased sedentary time in childhood can raise cholesterol levels by two thirds as an adult, leading to heart problems and even premature death - but a new study has found light physical activity may completely reverse the risks and is far more effective than moderate-to-vigorous physical activity.

Newswise: Prediabetes treatment may reduce heart and kidney risks in childhood cancer survivors
13-Dec-2023 12:05 PM EST
Prediabetes treatment may reduce heart and kidney risks in childhood cancer survivors
St. Jude Children's Research Hospital

Childhood cancer survivors have a higher prevalence of prediabetes and diabetes, which increases their risk of serious disease but also offers opportunities for prevention.

Released: 13-Dec-2023 2:05 PM EST
Deaths from heart valve infections drop across U.S. overall, but surged among young adults
American Heart Association (AHA)

An analysis of death certificate data from 1999 to 2020 showed a decline in deaths related to infective endocarditis throughout most of the United States yet found an alarming increase of 2%-5% among adults ages 25-44.

Newswise: National cardiogenic shock initiative study results show significant increase in heart attack survival
Released: 13-Dec-2023 11:05 AM EST
National cardiogenic shock initiative study results show significant increase in heart attack survival
Henry Ford Health

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

Released: 13-Dec-2023 10:05 AM EST
Kidney disease linked to increased mortality after stroke thrombolysis
Wolters Kluwer Health: Lippincott

Renal dysfunction, especially chronic kidney disease, is the biggest risk factor of mortality among thrombolysed stroke patients, according to a retrospective cohort observational study published in Medicine®, a journal published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Unique Cell-Based Approach for Pulmonary Arterial Hypertension Shown to Be Safe
Released: 13-Dec-2023 10:05 AM EST
Unique Cell-Based Approach for Pulmonary Arterial Hypertension Shown to Be Safe
Cedars-Sinai

Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects middle-aged women, according to a study led by Cedars-Sinai investigators.

Released: 12-Dec-2023 12:20 PM EST
Children who are sedentary may have a higher risk of heart attack or stroke later in life
Endocrine Society

Children who are physically inactive may have high cholesterol in early adulthood and subsequent heart health issues in their mid-forties, according to new research published in The Journal of Clinical Endocrinology & Metabolism.

Released: 12-Dec-2023 11:05 AM EST
FluidForm Bio Successfully Demonstrates Advancements in Engineered Heart Tissues with FRESH™ 3D Bioprinting
FluidForm Bio

FluidForm Bio, a leader in developing life-like human tissue to treat disease, shares recent advancements in building human cardiac tissues using FRESH™ 3D bioprinting. Recently published in APL Bioengineering, the research article FRESH™ 3D bioprinted cardiac tissue, a bioengineered platform for in vitro pharmacology addresses the critical need for a predictive model of human cardiac physiology in drug development.

   
Newswise: New 'atherosclerosis atlas' sheds light on heart attacks, strokes
Released: 12-Dec-2023 11:05 AM EST
New 'atherosclerosis atlas' sheds light on heart attacks, strokes
University of Virginia Health System

University of Virginia School of Medicine researchers have created an “atlas of atherosclerosis” that reveals, at the level of individual cells, critical processes responsible for forming the harmful plaque buildup that causes heart attacks, strokes and coronary artery disease.

Newswise: Clinical trial finds cell therapy improves quality of life in advanced heart failure
Released: 12-Dec-2023 10:05 AM EST
Clinical trial finds cell therapy improves quality of life in advanced heart failure
Mayo Clinic

Stem cell-based therapy improved quality of life for patients with advanced heart failure, Mayo Clinic researchers and international collaborators discovered in a late-stage multinational clinical trial.

Newswise: Baylor Scott & White Heart and Vascular Hospital – Dallas Becomes First Hospital in Texas to Deploy New FDA-Approved Hypertension Treatment
Released: 12-Dec-2023 7:30 AM EST
Baylor Scott & White Heart and Vascular Hospital – Dallas Becomes First Hospital in Texas to Deploy New FDA-Approved Hypertension Treatment
Baylor Scott and White Health

Baylor Scott & White Heart and Vascular Hospital – Dallas has added an innovative, minimally invasive option for patients with hypertension, or high blood pressure.

Not for public release

This news release is embargoed until 11-Dec-2023 5:00 PM EST Released to reporters: 5-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 11-Dec-2023 5:00 PM EST Released to reporters: 5-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 11-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: A shape-shifting robotic catheter could make heart surgery safer
Released: 8-Dec-2023 10:40 AM EST
A shape-shifting robotic catheter could make heart surgery safer
National Institute of Biomedical Imaging and Bioengineering

A beating heart makes for a formidable surgical arena, but a new robotic catheter could someday equip surgeons to operate in the cardiac environment with greater ease.

Released: 7-Dec-2023 10:05 AM EST
Use of anticoagulant drug after aortic valve replacement lowers mortality risk, Mayo Clinic study finds
Mayo Clinic

Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of blood clots, according to a retrospective study published in Mayo Clinic Proceedings.

Released: 6-Dec-2023 2:05 PM EST
New study finds many couples around the world may share high blood pressure
American Heart Association (AHA)

A study of married or partnered, middle-aged and older heterosexual couples in the U.S., England, China and India found that in 20% to 47% of the couples, both spouses/partners had high blood pressure.

Not for public release

This news release is embargoed until 4-Dec-2023 5:00 PM EST Released to reporters: 28-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 4-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Physical Therapy for Long COVID: Research Shows Patients Benefit
Released: 4-Dec-2023 7:05 AM EST
Physical Therapy for Long COVID: Research Shows Patients Benefit
Philadelphia College of Osteopathic Medicine

Studies show that those suffering from long COVID may benefit from physical therapy services as soon as they are able to tolerate physical activity, a PCOM Georgia assistant professor, who specializes in cardiopulmonary physical therapy, said.

Newswise: Cedars-Sinai Guerin Children’s Selects Pediatric Intensivist to Direct Congenital Cardiac Critical Care
Released: 1-Dec-2023 10:05 AM EST
Cedars-Sinai Guerin Children’s Selects Pediatric Intensivist to Direct Congenital Cardiac Critical Care
Cedars-Sinai

David Epstein, MD, a pediatrician who has dedicated his career to caring for very ill children, has been selected as the new director of Pediatric and Congenital Cardiac Intensive Care at Cedars-Sinai Guerin Children’s.

Released: 1-Dec-2023 7:00 AM EST
Clinical smart watch finds success at identifying atrial fibrillation
Michigan Medicine - University of Michigan

Researchers have developed a prescription wristwatch that continuously monitors the wearer’s heart rhythm and uses a unique algorithm to detect atrial fibrillation.

Newswise: November Research Highlights
Released: 30-Nov-2023 11:05 AM EST
November Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: First Multi-Chamber Heart Organoids Unravel Human Heart Development and Disease
Released: 29-Nov-2023 6:05 PM EST
First Multi-Chamber Heart Organoids Unravel Human Heart Development and Disease
Institute of Molecular Biotechnology

Heart disease kills 18 million people each year, but the development of new therapies faces a bottleneck: no physiological model of the entire human heart exists – so far.

Newswise:Video Embedded how-can-adults-with-congenital-heart-disease-reduce-risks-study-finds-lifetime-cardiology-monitoring-is-key
VIDEO
Released: 29-Nov-2023 3:05 PM EST
How can adults with congenital heart disease reduce risks? Study finds lifetime cardiology monitoring is key
Mayo Clinic

Heart failure is a potentially urgent health concern for young adults with congenital heart disease (ACHD) that is often overlooked and undertreated, even as hospitalizations for this condition continue to rise.

Newswise: Supplement lowers risk of higher glucose caused by blood-pressure drug
Released: 29-Nov-2023 12:05 PM EST
Supplement lowers risk of higher glucose caused by blood-pressure drug
UT Southwestern Medical Center

A dietary supplement developed by a UT Southwestern Medical Center researcher significantly reduced high blood sugar caused by a diuretic used to lower blood pressure while also correcting electrolyte imbalances, UTSW researchers report. The findings, published in Hypertension, could offer a solution for the serious side effects associated with this class of drugs.

Newswise: Novel Study Finds Aspirin-free Regimen Benefits Patients with LVAD
Released: 29-Nov-2023 12:05 PM EST
Novel Study Finds Aspirin-free Regimen Benefits Patients with LVAD
University of North Carolina School of Medicine

The clinical trial, led by Mirnela Byku, MD, PhD, MBA, at the UNC School of Medicine, found that excluding aspirin from the antithrombotic regimen in patients with a levitated left ventricular assist device is safe.

Released: 28-Nov-2023 6:05 PM EST
Access Remains the Most Serious Barrier to Cardiac Rehabilitation
Elsevier

Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023) observed that although cardiac rehabilitation benefits diverse groups of patients and affords the most cost-effective prevention for recurrent events, it is grossly underutilized globally.

Released: 28-Nov-2023 3:05 PM EST
New findings on long-term treatment of ADHD and its link to cardiovascular disease
Karolinska Institute

A large proportion of patients who start taking ADHD medication, especially young adults, stop within the first year. However, people who use ADHD medicine for a long time and in higher-than-average doses seem to have a higher risk of some cardiovascular diseases.

Released: 28-Nov-2023 2:05 PM EST
Access remains the most serious barrier to cardiac rehabilitation
Elsevier

Noted experts in cardiovascular rehabilitation attending the Third Jim Pattison-Mazankowski Alberta Heart Institute Cardiac Rehabilitation Symposium (Banff, April 21-23, 2023) observed that although cardiac rehabilitation benefits diverse groups of patients and affords the most cost-effective prevention for recurrent events, it is grossly underutilized globally.

Newswise: Radiation therapy may be potential heart failure treatment
27-Nov-2023 3:05 PM EST
Radiation therapy may be potential heart failure treatment
Washington University in St. Louis

In diseased hearts, low-dose radiation therapy appears to improve heart function. The research, from Washington University School of Medicine in St. Louis, could lead to new heart failure therapies.

27-Nov-2023 12:00 PM EST
Breathing highway air increases blood pressure, UW research finds
University of Washington

A new study from the UW found that unfiltered air from rush-hour traffic significantly increased passengers’ blood pressure, both while in the car and up to 24 hours later. 

Released: 27-Nov-2023 9:05 AM EST
Alarming Trends in Cardiovascular Health Among Middle-Aged Adults
Beth Israel Deaconess Medical Center

New research helps explain the recent reversal in cardiovascular mortality among this population and underscores the need to address the social determinants of health that contribute to it.

Released: 27-Nov-2023 9:00 AM EST
Alcohol Consumption May Have Positive and Negative Effects on Cardiovascular Disease Risk
Tufts University

A new study finds that alcohol consumption may have counteractive effects on cardiovascular disease risk, depending on the biological presence of certain circulating metabolites—molecules that are produced during or after a substance is metabolized and studied as biomarkers of many diseases.

Released: 23-Nov-2023 7:00 AM EST
¿Quiénes se benefician de la administración de estatinas?
Mayo Clinic

Si usted corre el riesgo de enfermedad cardíaca, el equipo de atención médica podría utilizar la herramienta de la ecuación de cohorte agrupada para determinar su riesgo a largo plazo y si la administración de estatinas (medicamentos para reducir el colesterol) es una buena opción.

Released: 23-Nov-2023 7:00 AM EST
من الذي يستفيد من تناول أدوية خافِضة للكوليسترول؟
Mayo Clinic

مدينة روتشستر، ولاية مينيسوتا—إذا كنت مهددًا بخطرالإصابة بمرض القلب فقد يستخدم فريق الرعاية الصحية أداة معادلة تقييم المخاطر المُشتركة بين الفئات العمرية(PCE)  لتحديد خطر إصابتك على المدى الطويل وما إذا كان تناول أدوية خافِضة للكوليسترول — أدوية خفض الكوليستيرول، خيار مناسب لك أم لا.

Released: 23-Nov-2023 7:00 AM EST
Quem se beneficia com a administração de estatinas?
Mayo Clinic

Se você está sob o risco de ter uma doença cardíaca, a equipe de cuidados médicos pode usar a ferramenta de equação de coorte agrupada (PCE) para determinar o seu risco de longo prazo, e se a administração de estatinas (medicamentos para reduzir o colesterol) é uma boa opção.

Newswise: After Multiple Organ Transplants, Grateful for 25 Extra Years
Released: 22-Nov-2023 10:05 AM EST
After Multiple Organ Transplants, Grateful for 25 Extra Years
Cedars-Sinai

This Thanksgiving marks a little more than 25 years since Christine Galan became the first person in the Western U.S. to have a combined organ transplant (heart and liver), and nearly five years since she returned to Cedars-Sinai for another organ transplant—this time, a kidney.



close
2.70019